Member Info for Uncanny

Here you go Martc 2018 Personalized Medicine 5(5): 441-445 ValiRx plc ValiRx plc is a therapeutics and diagnostics company developing an integrated approach to the diagnosis, treatment and prognosis of cancer through its two subsidiaries; ValiPharma and ValiBio. Over 95% of cellular DNA is tightly packaged into a complex structure called chromatin, with only 1% available to be read by cell's machinery. ValiRx's two proprietary technology platforms exploit this epigenomic structure. ValiBio is developing low-cost, rapid, high-throughput, noninvasive screening tests for the early detection, differential diagnosis and prognosis of cancer using its patented Hypergenomicsâ„¢ and Nucleosomicsâ„¢ technology. Its therapeutics subsidiary, ValiPharma, is developing novel gene-silencing therapeutics based on its GeneICEâ„¢ technology platform, which works by repackaging specific open areas of DNA, resulting in targeted gene deactivation. HyperGenomics and GeneICE are synergistic but independent business areas based on the company's core patent portfolio. ValiRx intends to facilitate early, optimal personalized treatment regimes by correlating 'hypersensitive' site profiles within the genome to specific types of cancer.

Does this mean news next week like the week before?

Yea I can see it.... presume its a worked buy as best side of the mid price. It days its an off-book trade.

That would be a nice Xmas present!

Hoping for 10p to 20p with 401 JV which hopefully is sooner rather than later. The next big milestone will be when 201 CTIl is complete, unless the dosage escalataion shows such compelling results that pharmas want to snap VALs hands off and do a deal sooner

Woody Quite sad really if some people have to criticise, try and manipulate and bad mouth fellow human beings to make money. Not to mention putting our investments down which potentially could sway some PI’s to sell, so effectively they’re messing with people lives and families, as I for one want to make money to hive my family a better a life.

No, I’d like to know - he all knows who is long as we have nothing to hide and admitted it. He can still stay annoymous as its a BB and I’m sure Chelsea isn’t his real name.

How could a commercial deal have happened anytime before June this year? VAL was not in a position to start JV talk? Yes keep topping up and will continue to. As you know I am long Chelsea, tell me what you are - long, short, long term holder, looking to buy in cheap or have no holding long or short? Thx

Chelsea, how does that post contribute to anything meaningful to the BB? BTW, It was a £17k sell of 1mn shares, which is incidentally the same size that I bought over the last week, plus there was still more buyers than sellers today.

Study completion date June 2019, but will the market get an update pre-completion date? “Further results will be announced as they become available and have been verified.“

Study completion date June 2019, but will the market get an update pre-completion date? This weeks RNS said “Further results will be announced as they become available and have been verified.” ???

Thoth2 Any idea when it will complete - Suzy said in the final stages in this weeks RNS. By EOY? I agree, 401 commercialsiation is exciting as a milestone for the company but 201 is a game changer in terms of market size, value and potential volumes for VAL.

I wonder who did those trades on Friday? Then 2 RNS’s follow in 3 days saying 201 and 401 all on track and two more ducks lined up. Looks like the overhang of placing shares - 0.2p profit or £2000. Bird in the hand and all that.

Someone confident and seen the news!

Someone confident and seen the news!

Someone confident and seen the news!0

I think hits the nail on the head: Tbh Abey, everything looking good this week - two more ducks lined up! 401 JV is going to be a comforter for the mkt to show that they can commercialise their compound(s). Why would they escalate to CTlll if not? 201 will hopefully be a behemoth and a game changer in time. GLA, I think a rerating is in the mix looking at the buys of late.

Looking good! “All of the current patients have received the escalated dose, meaning VAL201 is now on the home stretch of the early-stage study”

Things do feel a lot more upbeat now with 2 RNS’s this week. I guess with SP weakness, th BoD teying to alleviate fears. Now 401 JV hopefully sooner rather than later!

Trader John - love to be proved wrong that news this week, but doubt it. You talking about 401 JV?